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Abdominal compartment syndrome’s manifestations are diﬃcult to deﬁnitively detect on physical examination alone. Therefore,
objective criteria have been articulated that aid the bedside clinician in detecting intra-abdominal hypertension as well as the
abdominal compartment syndrome to initiate prompt and potentially life-saving intervention. At-risk patient populations should
be routinely monitored and tiered interventions should be undertaken as a team approach to management.
1.Introduction
The concepts of intra-abdominal hypertension (IAH) and
abdominal compartment syndrome (ACS) are pervasive,
but the objective criteria by which to diagnose each of
these entities are often misunderstood [1]. IAH and ACS
occur in both medical and surgical Intensive Care Units
(ICU), the general ward, and may even occur the Emergency
Department. Successful outcomes rely on early and accurate
diagnosis combined with timely therapy [2–4]. Herein
we describe these conditions, identify the at-risk patient
populations, review diagnostic techniques as well as tiered
medical management strategies, acute surgical therapy and
long-term interventions to improve patient safety, optimize
survival, and decrease morbidity.
2. Epidemiology
Changes in ﬂuid resuscitation paradigms, such as Early
Goal Directed Therapy (EGDT) in the medical realm, and
“damage control resuscitation” in the trauma realm, have
increased patient survival [5, 6]. As a result of vigorous
ﬂuid resuscitation, however, each has also been associated
with an unanticipated and undesired consequence—intra-
abdominal hypertension and abdominal compartment syn-
drome (ACS). Given the detrimental eﬀects of ACS (organ
failure and death), heightened awareness surrounding the
recognition of IAH and its progression to ACS, as well as the
reportingofACS,isparamountforoptimalpatientcare.IAH
is estimated to occur in 32.1% of ICU patients, and ACS has
beenreportedinupto4.2%ofpatientsrequiringcriticalcare
[7]. In order to identify each of these, one must be familiar
with their deﬁnitions.
3. Deﬁnitions
According to the World Society of the Abdominal Compart-
ment Syndrome (WSACS), ACS may be deﬁned as sustained
intra-abdominal pressure (IAP) of >20mmHg with the
presence of an attributable organ failure [8]. While the
WSACS has deﬁned the parameters of ACS, it is important
to delineate ACS from its predecessor, intra-abdominal
hypertension. Absent from any disease processes, the average
intra-abdominal pressure ranges from 5 to 7mmHg with a
normal upper limit of 12mmHg [8]. Thus, a sustained IAP
greater than 12mmHg, according to the WSACS, deﬁnes2 Critical Care Research and Practice
IAH. When evaluating the eﬀects of IAH relative to organ
perfusion, a more useful metric is abdominal perfusion
pressure (APP). This is calculated by subtracting the IAP
frommeanarterialpressure(MAP).Hence,APP =MAP-IAP
(normal = 60mmHg) [8].
4. At-Risk PatientPopulations
Betro and Kaplan have described three patient popula-
tions that are most likely to develop ACS—the postoper-
ative injured patient that experienced near-exsanguination,
medical patients that have undergone large volume ﬂuid
resuscitation for severe sepsis, and the general surgical
patient that required large volume resuscitation for an intra-
abdominal catastrophe regardless of etiology. Patients with
thermal injury also receive large volume ﬂuid resuscitation
and do so in the setting of capillary leak that may lead to
rapid ascites accumulation and increased intra-abdominal
pressure as well [9]. Major risk factors for the development
of IAH and ensuing ACS are large volume resuscitation,
massive transfusion protocol use, management with an
open body cavity, core hypothermia, coagulopathy requiring
component therapy, severe sepsis or septic shock, critical
illness in the setting of cirrhosis or other liver failure
accompanied by extant ascites, mechanical ventilation, and
PEEP > 10cm H2Op r e s s u r e[ 8, 10]. In a similar fashion,
extremity compartment syndromes can be aggravated by
large volume ﬂuid resuscitation as well, although these
syndromes are not the topic of this paper.
5.Monitoring
Accurate and reliable monitoring of IAP is essential when
IAH or ACS is suspected. The current “gold” standard for
monitoring IAP is the intravesicular technique [10]. This
method uses an indwelling urinary catheter, a pressure
transducer, and a syringe or similar device, capable of
infusing ﬂuid. Advantages of this technique are its reliability,
relative noninvasiveness, and elementary process. Using a
closed (as opposed to an intermittently accessed or open)
system presents no discernable risk of urinary tract infection
[11]. In comparison, the gastric method is more cost-
eﬀe c t i v e ,c o r r e l a t e sw e l lw i t hi n t r a v e s i c a lp r e s s u r e ,b u tm a y
be acutely contraindicated in speciﬁc patient populations—
gastriclacerationrepair,ileusorbowelobstructionwithlarge
volume gastric aspirate, and partial or total gastric resection
[12]. Another means to measure IAP is via the inferior vena
cava (IVC). A catheter is placed into the IVC through the
right (easier) or left common femoral vein [13]. Although
this monitoring technique oﬀers continuous real-time data
there are more risks associated with this method such as
thrombosis, venous thromboembolism, venous or arterial
laceration,femoralnerveinjury,hematomaformation,pseu-
doaneurysm formation, and central line associated blood
stream infection (CLABSI) [14].
While the intravesicular technique is readily accepted as
the “gold” standard, there is, however, controversy regarding
the most appropriate amount of ﬂuid to instill into the
otherwise empty bladder. The typical amount of normal
saline that is infused ranges from 25cc to 50cc [8, 10, 15].
The current recommendation by the WSACS is that no more
than 25cc be instilled into the bladder to avoid coaptation
of the bladder walls around the measuring catheter [8, 10].
Greater volumes of bladder instillate degrade the ﬁdelity of
themeasurementandmayprovidetheclinicianwithafalsely
elevated reading leading to inappropriate therapy [15]. Fur-
thermore, correct placement of the transducer and correct
timing of the measurement play a vital role in accuracy of
the data. The transducer should be placed at the phlebostatic
axis and the measurement taken at end expiration [8]. While
muscular activity may aﬀect the measurement, Betro and
Kaplan suggest a temporary increase in sedation to reduce
this confounder as opposed to the use of neuromuscular
blockade [9]. A potential monitoring scheme is provided in
Table 2.
6. Grades and Types of ACS
The WSACS has categorized IAH into grades, based upon
worsening abdominal pressures (Table 3). Moreover, based
on the etiology of the IAH, ACS can be deﬁned as primary,
secondary, or recurrent [8]. Primary ACS is predominantly
associated with hemorrhage in either the peritoneal or
retroperitoneal spaces and often accompanies injury. Sec-
ondary ACS occurs as a result of organ edema or ascites
formation following a large volume ﬂuid resuscitation and
visceral reperfusion injury. This form of ACS is common in
patients who have undergone large volume ﬂuid therapy for
sepsis resuscitation as well as burn management. It remains
unknown whether in such circumstances secondary ACS is
avoidable or an unavoidable accompaniment of the primary
disease process. Recurrent ACS or “tertiary ACS,” as it was
formerly known, occurs in lieu of prior medical or surgical
intervention for primary or secondary ACS. This is typically
seen in patients with recurrent hemorrhage or persistent
accumulation of ascites [8, 10].
7.Pathophysiology
The pathophysiology of IAH has been described in many
organ systems. The cardiac system is aﬀected when IAPs
are elevated because the external pressure exerted on the
inferior vena cava leads to diminished venous return and
thus decreased cardiac output [18]. The pulmonary sys-
tem is aﬀected largely because of pressure-induced cepha-
lad displacement of the hemidiaphragms and creating a
functional restriction of diaphragmatic excursion and pul-
monary expansion. Patient’s exhibit decreased respiratory
compliance, hypoxemia (relative or absolute), decreased
CO2 clearance, and distorted pulmonary ﬂow characteristics
[19]. Renal dysfunction manifesting as increased serum
creatinine and oliguria is multifactorial. Extrinsic renal
vein compression, as well as increased venous impedance
fromIVCcompressioncausedecreasedglomerularﬁltration,
upregulation of antidiuretic hormone, and activation of the
rennin-angiotensin system stimulating water conservationCritical Care Research and Practice 3
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Figure 1: A tiered approach to IAH management (adapted from [16, 17]).
[10, 20]. The decreased cardiac output secondary to dimin-
ished venous return may also lead to acute tubular necrosis
[18, 20]. One should note that rhabdomyolysis secondary
to muscle crush injury may also lead to renal failure. In
addition, the central neuraxis, liver, and gastrointestinal
tract similarly suﬀer hypoperfusion, and when relieved,
subsequent reperfusion injury manifested as visceral edema;
the brain may be somewhat more protected by virtue of the
properties of an intact blood-brain barrier.
8. Therapy
Both medical and surgical therapies have been described for
IAH and ACS and need not be mutually exclusive. Medical
management has been described in a tiered fashion and
targets managing pressure-volume relationships in both the
peritoneal space as well as the gastrointestinal tract therefore
seeking to reduce intra-abdominal pressure ([16, 17], Figure
1). They more commonly provide only temporary IAP
managementalthoughdeﬁnitivetherapymaybeachievedfor
conditionssuchasACSstemmingfromlargevolumegaseous
colonic distension. In certain circumstances, neuromuscular
blockade may be helpful in eliminating abdominal wall
muscular tone to acutely manage or accurately measure
IAP [16, 17]. However, this modality is surrounded by
controversy and may not be appropriate for longer periods
of time. No prospective randomized controlled studies
exist to compare medical methods management to surgical
techniques due to a lack of clinical equipoise regarding the
need for deﬁnitive therapy when ACS is diagnosed. In that
circumstance, surgical therapy provides deﬁnitive relief.
Nonetheless, since visceral edema and ascites are com-
mon accompaniments of secondary ACS, it is appropriate
to review management options (see Table 1). Strategies to
reduce intravascular volume include the use of potent loop
diuretic agents such as furosemide, as well as and renal
replacement therapy (RRT). Furosemide not only reduces
intravascular volume but can also reduce bowel wall edema,
leading to lower IAP. Acute kidney injury (AKI) as identiﬁed
by the Acute Dialysis Quality Initiative and Acute Kidney
Injury Network RIFLE criteria and oliguria are typically
present in this population, despite volume resuscitation and
t o t a lb o d ys a l ta n dw a t e re x c e s s[ 21, 22]. As such, given
the hemodynamic lability of those with IAP and incipient
ACS, RRT may have a role in managing metabolic clearance
a sw e l la st o t a lb o d ys o l u t el o a d .T h er e a d e rs h o u l dn o t e
that RRT is generally not required for the management of
all but late-stage AKI. Relatedly, appropriate vasopressor
use as an adjunct in managing mean arterial pressure may
serve to limit the total volume of ﬂuids that are utilized
in resuscitation. Management using a ﬂuid “cap” has been
described in one series and was associated with a reduced
incidenceofIAHandACS[23].Additionally,otherstrategies
such as pulse pressure variation, pulse power, esophageal
Doppler analysis, or transthoracic bioimpedance techniques
may serve as guides to judicious ﬂuid administration [24,
25].
Reductions in small and large bowel volume may also
decrease IAP. The choice of technique depends on the cause
of the luminal distension. If there is fecal impaction rectal
lavage may be helpful especially when combined with an
oral cathartic such as a polyethylene-glycol lavage solution.
Gaseous gastric or liquid distension may be managed with
oro- or nasogastric tube insertion and aspiration. This has
shown to be helpful in small bowel obstruction management
insome(butnotall)patientseries[26].Nasogastricdrainage
is logically most eﬀective in managing intra-abdominal
pressure when there is gastric distension. Finally, gastro-
and colonic-prokinetic agents, such as metoclopramide and
erythromycin ethylsuccinate (EES) may increase intestinal
transit time and evacuate luminal contents; some contro-
versy surrounds the eﬃcacy of these agents so they are4 Critical Care Research and Practice
Table 1: Common surgical options for ACS management.
Initial management of ACS
Minimally invasive
Percutaneous aspiration
Colonoscopic decompression of colonic distension
Invasive
Initial or relaparotomy
Open abdomen management (short-term; able to close primarily)
Vacuum assisted closure (proprietary of home-made)
Hook and Loop closure device
Open abdomen management (long-term; unable to close primarily)
Polyglycolic acid mesh and split-thickness skin graft (STSG)
STSG without underlying absorbable mesh
Component separation of parts with biologic mesh underlay (rare)
Fascial relaxing incisions with spanning mesh (prosthetic or biologic)
∗Caution: biologic may relax and gap when placed in spanning position
Reconstruction
Component separation of parts with biologic mesh underlay (common)
Primary closure + fascial relaxing incisions + biologic mesh underlay (less common)
Free muscle ﬂap + biologic mesh underlay (rare)
not universally recommended. In those without cardiac
disease, neostigmine may be particularly helpful when there
is gaseous colonic distension as in Ogilvie’s Syndrome [27].
Increasingly invasive, percutaneous catheter drainage
(with indwelling catheter placement) or large volume para-
centesis is another strategy to achieve intra-abdominal
volume reduction when the increased IAP or ACS is
due to massive ascites related to secondary ACS [28–30].
Technical diﬃculties may arise with such methods including
catheter kinking, malposition, secondary ascites infection,
andperforationofbowelorotherintra-abdominalstructures
including major vascular domains.
As noted earlier, other organ systems are aﬀected by
the distorted physiology that accompanies IAH leading to
ACS. As IAP increases and pulmonary compliance decreases,
oxygenation and ventilation are progressively compromised.
No single ventilator management strategy will overcome
the untoward eﬀects of rising IAP and ACS. However,
as a temporizing measure, either changing to a pressure
cycled mode with a prolonged inspiratory time, or using
Airway Pressure Release Ventilation (APRV), a modiﬁed
form of CPAP that uses high pressures to aid in alveolar
recruitment, are two methods to temporize oxygenation
and ventilation failure until deﬁnitive relief from ACS may
be accomplished. APRV in particular has been shown to
increase pulmonary ﬂow and increase cardiac output as
a result of decreasing pulmonary hypoxic vasoconstriction
[31].
As noted above, when medical management fails, or ACS
is present, surgical management is appropriate and generally
consists of decompressive laparotomy; minimally invasive
methods have been described but are not the standard or
care at present for primary or recurrent ACS. Decompressive
laparotomy may be performed in the OR or the ICU and
aﬀords rapid relief from ACS [32]. Such a laparotomy is
generally followed by a temporary abdominal wall closure
(of which there are many successful varieties) to create
a functionally enlarged peritoneal space to decrease the
likelihoodofrecurrentIAHandACS.Thereadershouldnote
that neither a homemade “VAC” (vacuum assisted closure),
nor the proprietary KCI device prevents ACS from recurring.
Thus, the bedside clinician should be vigilant and routinely
monitor such patients for rising IAP.
9. Postdecompression Care
While decompression may be done at virtually any facility
where there is a surgeon, the aftercare may be labor and
resource intensive for small facilities. Therefore, postdecom-
pression consideration should be made prior to transferring
such patients to a facility capable of rendering such care.
Generally an appropriate facility will be a level II or level I
trauma facility where there is an embedded and dedicated
ICU team as well as an in-house anesthesiologist and often
an in-house surgeon. These patients require at least one and
frequently several reexplorations prior to deﬁnitive closure,
many of which may be accomplished in the ICU under
deep sedation. Repeated temporary abdominal wall closure
is generally required prior to closure [33]. For those who
are unable to be closed at their ﬁrst reexploration, many
management options exist and may be categorized into (1)
techniques to stretch fascia, (2) fascial spanning techniques,
(3) component separation techniques with or without an
underlay of mesh (biologic or synthetic), and (4) temporary
mesh followed by a split thickness skin graft.Critical Care Research and Practice 5
Table 2: Bladder pressure monitoring guideline.
Patients covered
All ICU patients at risk for intra-abdominal hypertension.
Risk identiﬁers for increased intra-abdominal pressure (IAP):
(1) Damage control laparotomy.
(2) Intra-abdominal procedure in conjunction with large volume resuscitation (>10 liters crystalloid equivalent), or
Coagulopathy requiring correction with the massive transfusion protocol, or
Large volume blood component therapy (PRBC > 10 units, or FFP > 8 units).
( 3 )S e v e r es e p s i so rs e p t i cs h o c k .
(4) Open body cavity.
(5) Core hypothermia.
(6) Cirrhosis or liver failure with ascites.
(7) Mechanical ventilation with PEEP > 10cm H2O pressure (intrinsic or extrinsic).
(8) Physician discretion.
Deﬁnitions
(1) Intra-abdominal hypertension: IAP > 12mmHg.
(2) Abdominal compartment syndrome: a clinical syndrome resulting from increased IAP > 20mmHg coupled with an
attributable organ failure manifested as increased peak airway pressure, oliguria, metabolic acidosis, decreased cardiac performance
(mean arterial pressure, cardiac output, SvO2), decreased abdominal perfusion pressure, and decreased mentation. The ACS is
commonly associated with IAP > 20mmHg but may occur at lower pressures as well based on individual patient characteristics.
(3) Abdominal perfusion pressure (APP): Mean arterial pressure (MAP)-(IAP); Normal APP > 60mmHg
Guideline
(1) On admission to the ICU, patients will be evaluated by the bedside nurse and the physician team for risk identiﬁers for
increased IAP.
(2) Patients who are identiﬁed at-risk will be monitored by bladder pressure measurements according to the following schedule:
(a) On arrival to the SICU.
(b) Every 2 hours for the ﬁrst 8 hours.
(c) Every 4 hours for the next 8 hours.
(d) Every 8 hours for the next 24 hours.
(3) The ICU bedside team (physician and nursing) will decide on the frequency on IAP measurements after the ﬁrst 24 hours of
monitoring.
(4) The physician team will be notiﬁed of all bladder pressure measurements >12mmHg and abdominal perfusion pressures <
60mmHg.
(5) These values will be recorded on the nursing record.
Devices that are sutured to fascia and use a hook-
and-loop closure method progressively draw the edges of
separated fascia together to facilitate primary closure. The
Wittmann patch is one such device and has been used to
good eﬀect after injury [34]. Fascial spanning techniques
may rely on synthetic mesh such as polypropylene or
expanded polytetraﬂuoroethylene (Gortex), but have fallen
out of favor due to unfavorable infection and recurrence
rates. Spanning with acellular human dermis (AlloDerm)
has similarly fallen out of favor due to gapping of the
product over time creating a lax abdominal wall with
deleterious cosmetic and functional results [35]. Instead,
primary fascial closure coupled with an underlay of acel-
lular human or porcine dermis (Strattice) has excellent
results. Clinical results buttress the underlay technique as
an ideal manner in which to use biologic mesh [36]. A
multitude of other meshes are similarly available and may
be used in an identical underlay fashion with good results
as well.
A component separation of parts technique may enable
fascia to fascia approximation as well as support an underlay
of biologic or synthetic mesh. However, the operative time
is increased as is blood loss. Furthermore, this technique
may not be appropriate for heavily contaminated spaces as
it will open unexposed tissue planes to a large bacterial
innoculum. Of course, implanting any permanent mesh is
ill advised in the setting of heavy contamination, active
infection, and perhaps even inadvertent enterotomy [37].
In general, component separation techniques are typically
reserved for later reconstructive eﬀorts in those who were
unable to be closed during their initial hospitalization.
For those who remain open during their index hospital-
ization due to visceral edema or ﬁstula formation, placing an
absorbable mesh such as polyglycolic acid (Vicryl mesh) that
hydrolyzes over time while the underling viscera establish a
bed of granulation tissue is a commonly employed salvage
strategy. Once there is a covering bed of granulation tissue, a
STSG may be placed over the granulation bed and secured6 Critical Care Research and Practice
in place with a VAC device. There is no need to remove
any residual absorbable mesh provided that the entirety of
the mesh is embedded in granulation tissue; nonadherent
or nonincorporated mesh should be excised as part of the
tissue bed preparation at the time of skin grafting. Of course,
for those who have already adhesed their visceral block, no
absorbable mesh need to be placed and the viscera may be
directly skin grafted once there is an appropriate granulation
bed. The lack of an absorbable mesh often renders skin
graft removal for later reconstruction more diﬃcult in
one author’s view (LJK), but the technical diﬃculty is not
insurmountable.
10. Abdominal WallReconstruction
The timing of abdominal wall reconstruction is generally 6
to 12 months after the last operation to allow inﬂammation
to subside. It is unclear whether inﬂammation regression
may be accurately tracked by following c-reactive protein
levels, and study is underway to answer this question.
Nonetheless, a commonly used surrogate is the “pinch test”
that assess whether a skin graft may be rolled between the
examiner’s ﬁngers instead of remaining densely adherent to
the underlying viscera. Generally, if the pinch test is negative
by 12 months after the last abdominal operation, more
time will not be helpful. Reconstruction involves removing
the skin graft, lysing adhesions, restoring gastrointestinal
continuity if there is an ostomy, and then achieving fascia-
to-fascia closure. Component separation of parts, biologic
mesh underlay, pedicled rotational ﬂaps (tensor fascia lata),
and even free tissue transfers (latissimus dorsi muscle most
commonly) using microvascular techniques have all been
described to restore abdominal wall integrity [35]. Success
is enhanced by reductions in visceral adipose mass, tobacco
cessation, and repletion of lean body mass losses to support
wound healing. Careful attention to providing multivita-
mins, B12, vitamin C, and supplemental zinc are all aids
in wound healing following abdominal wall reconstruction;
patients on therapeutic glucocorticoids should also receive
vitamin A to mitigate against steroid-induced wound failure
[38]. While the occurrence of an inadvertent enterotomy
during ventral hernia repair is strongly associated with
postoperative surgical site infection and hernia recurrence,
whether colostomy or ileostomy takedown should occur as
a staged procedure to precede restoration of abdominal wall
integrity remains unknown [37].
11. Long-Term Results
The major complications of the surgical management of
ACS have been well chronicled and principally grouped into
mechanical, infectious, resource utilization, and quality of
life. The “natural history” of injured patients suﬀering form
ACS and receiving surgical therapy has been identiﬁed by
Fischer et al. Readmission, reoperation, enteroatmospheric
ﬁstula, long-term mechanical ventilation, and tracheostomy,
awidevarietyofinfections(pulmonary,surgicalsite,urinary
tract, and CLABSI) as well as rehabilitation or skilled
Table 3: Grades of intra-abdominal hypertension.
Grade Intra-abdominal pressure
I 12–15mmHg
II 16–20mmHg
III 21–25mmHg
IV > 25mmHg
nursing facility placement are key events that occur with
substantial frequency [39]. Nonetheless, outcomes after
intervention were good with a large proportion returning to
an independent functional status. A major factor inﬂuencing
outcome is quality of life (QOL). For this patient population,
the decrement in QOL stemming from having an ostomy
or a planned ventral hernia has been characterized but has
broadoverlapwithQOLdecreasesassociatedwithprolonged
I C Uc a r e[ 40]. Decreases in QOL have been noted for those
having prolonged ICU care regardless of cause. It is likely
that this is an underreported complication due to a lack of
investigationaswellasimprecisetoolsandthewell-described
transient nature of injured patients. US return to work rates
are similarly diﬃcult to interpret due to the relatively high
unemployment rates of inner city trauma patients [41].
12. FutureDirections
At present, we are behind the curve in diagnosing ACS.
Ideally, we would want to be able to diagnose incipient
ACS to intervene prior to the onset of end-organ damage.
All too often, AKI persist and may progress to acute renal
failure after what is thought to be expedient abdominal
decompression. As in many other organ systems, having
a readily identiﬁable biomarker of incipient organ system
damage would be ideal. Such a marker would be elevated
prior to the onset of renal tubular injury or increase in
serum creatinine. It would ideally be able to diﬀerentiate
the above from the decreased glomerular ﬁltration rate and
renal blood ﬂow that accompanies hypovolemia. No such
marker yet exists, recognizing that AKI does not stem from
hypoperfusion and is instead a toxic phenomenon [42].
It may be that a panel of multiple biomarkers addressing
multiple organ systems will be able to do so. Relatedly, such a
panelhasbeenarticulatedfortheonsetoffunisitis,sothereis
belief that such a panel may be identiﬁed for ACS-associated
o r g a ni n j u r ya sw e l l[ 43].
In a complementary fashion, improved understanding
of the human genome may be able to identify high-
risk patients based on their genomics or proteomics. We
remain in the infancy of understanding how genomics and
proteomics inﬂuence the response to injury and critical
illness. Nonetheless, such investigations have occurred in
patients undergoing thoracotomy as a means of under-
standing persistent postthoracotomy pain [44]. Patients
with a particular genetic proﬁle are at higher risk for
postthoracotomy pain persistence and as such fare better
with speciﬁc anesthetic technique modiﬁcations. This peri-
operative period of interaction between a patient’s speciﬁcCritical Care Research and Practice 7
genetic proﬁle and therapeutic intervention has been termed
the “perioptome” and may serve as a template for future
diagnostic and therapeutic interventions in a similar vein
[44].
Unexplored is the occurrence of organ speciﬁc compart-
ment syndromes. By way of example, patients with blunt
renal, splenic, or hepatic injury with an intact capsule may
have excessive organ pressure from a large and undrained
hematoma. In particular, intrarenal hemorrhage may create
the greatest risk as the kidney is bounded by a strong and
well-developed fascial envelope—Gerota’s fascia. We do not
currently measure intraorgan pressures, and in general do
not explore such injures, a byproduct of which is fascial
compartment decompression. At present, we have no means
of readily assessing for organ-speciﬁc compartment syn-
dromes. Another such organ is the lungs. We are continually
apprised of a plethora of airway pressure measurements, but
when they are elevated, our primary interventions include
gas delivery and volume manipulations as well as drainage
of pleural gas or ﬂuid collections. Only when there is
ACS is surgical intervention undertaken. While thoracic
compartment syndrome has been described, it is ONLY after
the chest is already open and then unable to be closed [45].
To date, there are no reports of thoracic cage decompression
for compartment syndrome and may represent a missed
opportunity for intervention.
13. Conclusions
Intra-abdominal hypertension and the abdominal compart-
ment syndrome are important to recognize and diagnose.
Routine bladder pressure monitoring is the key to appro-
priately enacting medical and surgical therapy designed to
mitigate against the untoward eﬀects of increased intra-
abdominal pressure. While labor intensive and resource con-
suming, surgical therapy for ACS is successful and restores
the majority of patients to an independent functional status.
Multiple adjunctive therapies are often required to optimize
outcome in this challenging subset of critically ill patients.
As such, early transfer to an appropriate center should be
considered with rising intra-abdominal pressures or after
the initial decompressive laparotomy. A multidisciplinary
approach is generally required to meet the intensive care,
general ward, convalescent, and reconstructive needs of
these patients. Further work is needed to deﬁne and deploy
strategies to mitigate against decrements in quality of life
following the critical care of the patient with an open
abdomen.
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